Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Academy/Journal Finder/Signal Transduction and Targeted Therapy

Molecular medicine

Signal Transduction and Targeted Therapy

Springer Nature (Nature Portfolio)

Signal transduction in physiological and pathological processes, and targeted therapeutics including biological agents and small-molecule drugs

ISSN 2095-9907 (print)ISSN 2059-3635 (online)Access Fully open access
Fully open accessPublishing model
Verified 2026-11Field-level — see each tab
CiteScoreNot yet verified
Impact FactorNot yet verified
QuartileQ1 2025 · SCImago
Article Fee (APC)Not yet verified
First DecisionNot yet verified
Acceptance RateNot disclosed by publisher

Overview

Signal Transduction and Targeted Therapy is published by Springer Nature (Nature Portfolio). Signal transduction in physiological and pathological processes, and targeted therapeutics including biological agents and small-molecule drugs

Key information

PublisherSpringer Nature (Nature Portfolio)
ISSN (Print)2095-9907
ISSN (Online)2059-3635
Publishing modelFully open access
CountryUnited Kingdom
FrequencyNot yet verified
Subject categoryMolecular medicine and targeted therapy
EditorDavid Kerr, Kang Zhang and Yu-Quan Wei (Editors-in-Chief)
EstablishedNot yet verified
SubmissionsNot yet verified

Editors-in-Chief as listed on the journal’s nature.com pages. The article processing charge is still to be verified.

Aims & scope

An international, peer-reviewed, open-access journal. It is multidisciplinary, spanning:

  • Molecular and cell biology
  • Pharmacology and medicinal chemistry
  • Computational chemistry
  • Systems biology and bioinformatics
  • Clinical medicine

Covers signal transduction in health and disease, and targeted therapeutics such as biological agents and small-molecule drugs. Publishes primary research as well as reviews.

From the journal’s nature.com pages (journal information, aims & scope) and DOAJ as returned by search, SCImago 2025 and PubMed records for the sample articles, November 2026.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.